RG-04857A

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameRG-04857A
Drug Alias NameRG-04857A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionC5a anaphylatoxin chemotactic receptor antagonistsComplement system proteins inhibitors
TargetsComplement system proteinsC5a anaphylatoxin chemotactic receptor
Therapy Area/IndicationsInflammationHypersensitivity, Immediate
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRhone-Poulenc SA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRhone-Poulenc SA
Active IndicationsN/A
Inactive IndicationsInflammationHypersensitivity, Immediate

Other Information

ATC CodeN/A
Related LinksN/A